Tri-Cities Tech Business Update
IsoRay cancer treatment technology used in lung implants
For the first time, Cesium-131 brachytherapy seeds developed by IsoRay, Inc., based in Richland, Wash., have been used in lung implants for treatment of lung cancer. Four Cesium-131 lung implants have been performed at Weill Cornell Medical Center since August. Cesium-131 was chosen based on its short half life and higher dose rate, which allows 99.8% of the treatment dose to be delivered by the time the sutures and mesh dissolve. IsoRay is the sole producer of the Cesium-131 brachytherapy seed, which is also currently used in the treatment of prostate cancer and ocular melanoma among other cancerous conditions. Contact Dwight Babcock at 520-240-4840.
